IFIH1 and interstitial lung disease: Additionally, ILD develops in 80% of Japanese patients with anti-MDA5 antibody-positive JDM, but only in 20% of UK/Ireland and 25.7% of US patients, indicating that the prevalence of ILD differs between ethnicities, even with the same autoantibodies [9,55,60].